For example, loss of PHD1 expression in breast cancer as well as overexpression of PHD1 in lung cancer cells both lead to suppressed cell proliferation and tumor formation (Zhang et al. 2009) (Xie et al. 2014). This evidence concerns the gene EGLN2 and lung cancer.